Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Hironobu, Sugita"'
Autor:
Takao Yamori, Yuichi Ishikawa, Kimie Nomura, Reimi Asaka, Hiroyuki Nishimura, Yumiko Mukai, Michiyo Okui, Hironobu Sugita, Kanami Yamazaki, Mariko Seki, Mutsumi Okamura, Shingo Dan
Supplementary Figure Legends 1-5 from Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9784c98945d9250ff3c6bbe0f6b995e5
https://doi.org/10.1158/0008-5472.22383932.v1
https://doi.org/10.1158/0008-5472.22383932.v1
Autor:
Takao Yamori, Yuichi Ishikawa, Kimie Nomura, Reimi Asaka, Hiroyuki Nishimura, Yumiko Mukai, Michiyo Okui, Hironobu Sugita, Kanami Yamazaki, Mariko Seki, Mutsumi Okamura, Shingo Dan
Supplementary Figures 1-5 from Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f3f4b14b6cbf2d3ff778a59322ccb0
https://doi.org/10.1158/0008-5472.22383929.v1
https://doi.org/10.1158/0008-5472.22383929.v1
Autor:
Takao Yamori, Yuichi Ishikawa, Kimie Nomura, Reimi Asaka, Hiroyuki Nishimura, Yumiko Mukai, Michiyo Okui, Hironobu Sugita, Kanami Yamazaki, Mariko Seki, Mutsumi Okamura, Shingo Dan
Supplementary Tables 1-4 from Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3ef16bf8dfdef4e9a48e1fcbd951935
https://doi.org/10.1158/0008-5472.22383923.v1
https://doi.org/10.1158/0008-5472.22383923.v1
Autor:
Takao Yamori, Yuichi Ishikawa, Kimie Nomura, Reimi Asaka, Hiroyuki Nishimura, Yumiko Mukai, Michiyo Okui, Hironobu Sugita, Kanami Yamazaki, Mariko Seki, Mutsumi Okamura, Shingo Dan
The phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in human cancers, and several agents targeting this pathway including PI3K/Akt/mammalian target of rapamycin inhibitors have recently entered clinical trials. One question is wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b016d3eb8f40372d749b221969bb435
https://doi.org/10.1158/0008-5472.c.6500711
https://doi.org/10.1158/0008-5472.c.6500711
Autor:
Takao Yamori, Yuichi Ishikawa, Kimie Nomura, Reimi Asaka, Hiroyuki Nishimura, Yumiko Mukai, Michiyo Okui, Hironobu Sugita, Kanami Yamazaki, Mariko Seki, Mutsumi Okamura, Shingo Dan
Supplementary Information from Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: In silico and Biological Evaluations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eade94b53992e80cb571772b631ca872
https://doi.org/10.1158/0008-5472.22383926
https://doi.org/10.1158/0008-5472.22383926
Autor:
Takashi Suzuki, Yoko Oshima, Fumiaki Shiratori, Tatsuki Nanami, Satoshi Yajima, Makoto Sumazaki, Mitsunori Ushigome, Hironobu Sugita, Magdalena Eberl, Hideaki Ogata, Tetsu Hayashida, Seigo Nakamura, Tsuyoshi Nakagawa, Hideaki Shimada
Publikováno v:
Molecular and Clinical Oncology. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c098685980e5e7e6957fb4d9652ba95
https://doi.org/10.3892/mco.2022.2563
https://doi.org/10.3892/mco.2022.2563
Autor:
Kentaro Murakami, Hisahiro Matsubara, Yoshihisa Saida, Satoshi Yajima, Koji Okabayashi, Yoko Oshima, Yuki Hirata, Sei Muraoka, Hideaki Shimada, Hironobu Sugita, Shinichi Kawai, Masahiko Murakami, Toshihiro Nanki, Fumiaki Shiratori, Rei Kato, Kimihiko Funahashi, Yuko Kitagawa, Yasuaki Nakajima, Shinichi Okazumi, Takeshi Yamashita, Martin Klammer, Hirotoshi Hasegawa, Takashi Suzuki, Yoshihisa Urita
Publikováno v:
Annals of Surgical Oncology. 28:4007-4015
Several recent studies suggest that serum anti-p53 antibodies (s-p53-Abs) may be combined with other markers to detect esophageal and colorectal cancer. In this study, we assessed the sensitivity and specificity of s-p53-Abs detection of a new electr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64486c07ba7f2ea97965679fbad5d32a
https://doi.org/10.1245/s10434-020-09342-4
https://doi.org/10.1245/s10434-020-09342-4
Autor:
Shinji Ohno, Shinobu Masuda, Kenichi Togashi, Rie Horii, Hitoshi Tsuda, Futoshi Akiyama, Hironobu Sugita
Publikováno v:
Breast Cancer. 27:1058-1064
Although Ki67 has important clinical relevance in breast cancer, its assessment results vary according to assay due to differences in both analytical and interpretation processes. We aimed to validate the performance of anti-Ki67 antibody clone 30-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8f7843519ee7106e820cd26a1e07fcb
https://doi.org/10.1007/s12282-020-01108-w
https://doi.org/10.1007/s12282-020-01108-w
Publikováno v:
Quarterly Report of RTRI. 56:256-261
The adhesion coefficient between rail and wheel of the railway vehicle is reduced under rainy weather, so it is difficult to obtain high braking performance. In general, the braking performance of the train is evaluated to be based on the stopping di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ed8a3082df6f172a5a89b3faefad096
https://doi.org/10.2219/rtriqr.56.4_256
https://doi.org/10.2219/rtriqr.56.4_256
Autor:
Kanami Yamazaki, Mariko Seki, Hiroyuki Nishimura, Michiyo Okui, Takao Yamori, Yuichi Ishikawa, Reimi Asaka, Kimie Nomura, Shingo Dan, Mutsumi Okamura, Yumiko Mukai, Hironobu Sugita
Publikováno v:
Cancer Research. 70:4982-4994
The phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in human cancers, and several agents targeting this pathway including PI3K/Akt/mammalian target of rapamycin inhibitors have recently entered clinical trials. One question is wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adb2610fefe848651cb05373d6ddfa09
https://doi.org/10.1158/0008-5472.can-09-4172
https://doi.org/10.1158/0008-5472.can-09-4172